Showing results (171-180 of 262) with videos related to

Sort By:
Pageof 27
The Journal of Pathology|September 1, 2019
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancerIlaria Alborelli, Katharina Leonards, Sacha I Rothschild, et al.
Nature Cell Biology|October 20, 2020
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxiaMaria Saliakoura, Matteo Rossi Sebastiano, Chiara Pozzato, et al.
Cancer Research|January 4, 2008
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cellsShyh-Han Tan, Ayush Dagvadorj, Feng Shen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinomaSilvia Guglietta, Anne Bärenwaldt, Anthony Sonrel, et al.
NPJ Precision Oncology|November 3, 2023
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancerMichele Garioni, Viviane J Tschan, Lauriane Blukacz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2012
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07)Richard Cathomas, Christian Rothermundt, Dirk Klingbiel, et al.
International Journal of Cancer|December 31, 2013
MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancerDavid Adler, Roopika Menon, Martin Braun, et al.
Pageof 27